Ronald B Natale MD

Oncology•West Hollywood, CA

Professor of Medicine, University Mich Medical School

Join to View Full Profile

8700 Beverly Blvd#Ac1042bWest Hollywood, CA 90048
Phone+1 310-423-1101
Fax+1 310-659-3928

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1977 - 1980
Wayne State University School of MedicineResidency, Internal Medicine, 1974 - 1976
Wayne State University School of MedicineClass of 1974

Certifications & Licensure

NY State Medical License 1978 - Present
CA State Medical License 1993 - 2026
MI State Medical License Active through 1994
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014
Top Doctors:LA Area Castle Connolly, 2013
America's Top Doctors for Cancer Castle Connolly, 2005-2013
Top Doctors:Southern California Castle Connolly, 2012
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2002 Nov 01
Completed
Phase 3
Bortezomib (Velcade) + Pemetrexed (Alimta) in Advanced NSCLC Start of enrollment: 2006 Jan 01
Unknown status
Phase 1, Phase 2
Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2010 Feb 01
Terminated
Phase 3
Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer Start of enrollment: 2011 Jan 11
Terminated
Phase 3
Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for Advanced or Recurrent Disease Start of enrollment: 2012 Jul 01
Completed
Phase 1
A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants Start of enrollment: 2013 Aug 01
Completed
Phase 2
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
ACTIVE_NOT_RECRUITING
PHASE3
Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer Start of enrollment: 2020 May 28
ACTIVE_NOT_RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

Low booster uptake in cancer patients despite health benefits.
Jane C Figueiredo, Julia Levy, So Yung Choi, Alexander M Xu, Noah M Merin
Iscience. 2024-09-20
1 citations
Safety and Efficacy Outcomes From a Single-Center Study of Image-Guided Percutaneous Microwave Ablation for Primary and Metastatic Lung Malignancy.
Stephen M Chan, Peter J Julien, Peter Kaganjo, Robert J McKenna Jr, Charles Forscher
JTO Clinical and Research Reports. 2023-02-01
Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study.
Jun Gong, Michelle Guan, Haesoo Kim, Natalie Moshayedi, Sejal Mehta
Oncotarget. 2022-11-02

Journal Articles

Predictive Biomarkers for Response to EGFR-Directed Monoclonal Antibodies for Advanced Squamous Cell Lung Cancer
D R Spigel, E S Kim, S S Ramalingam, M A Socinski, C Obasaju, C J Langer, R B Natale, P D Bonomi, H Wakelee, Annals of Oncology

Press Mentions

36-Year-Old Yoga Instructor’s Swollen Face Dismissed as Viral Infection, but It Turned Out to Be Stage 4 Lung CancerMarch 26th, 2025
Cancer Nearly Gone for Redondo Beach Mayor Bill BrandMay 28th, 2021

Grant Support

Core--Clinical Investigations Support FacilityNational Cancer Institute1996–2000
Southwest Oncology GroupNational Cancer Institute1995–1996
Southwest Oncology GroupNational Cancer Institute1985–1993
Testing The Predictions Of A Human Tumor Cloning AssayNational Cancer Institute1985–1987

Other Languages

Italian